Multiomic study addresses long-standing diversity gap in pancreatic tumor data
Cincinnati, Ohio — November 17, 2026.
Researchers at the University of Cincinnati Cancer Center have uncovered measurable biological and immune-environment differences inside pancreatic tumors across diverse patient groups, offering new clues into why outcomes vary sharply and how future therapies might be tailored, according to the University of Cincinnati, Fox News, and AOL.
Published in the peer-reviewed journal Cancer Research, the study was led by Nina Steele, Ph.D., an assistant professor in UC’s College of Medicine, in collaboration with Howard Crawford of the Henry Ford + Michigan State University Pancreatic Cancer Center. Using a large-scale multiomic analysis, the team mapped tens of thousands of molecular markers to overcome a historical underrepresentation of diverse cohorts in pancreatic cancer datasets.
